https://www.law360.com/appellate/articles/1532/federal-circuit-rules-for-nintendo-in-patent-case?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T12:47:32Z monthly 0.5 https://www.law360.com/appellate/articles/1528/appeals-court-bars-andrx-from-using-altotocor-brand-name?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T06:34:22Z monthly 0.5 https://www.law360.com/appellate/articles/1510/appeals-court-rules-for-vicor-in-power-patent-suits?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T02:34:38Z monthly 0.5 https://www.law360.com/appellate/articles/1502/appeals-court-remands-microsoft-trademark-case-to-district-court?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T11:11:24Z monthly 0.5 https://www.law360.com/appellate/articles/1495/canada-supreme-court-rules-for-monsanto-in-closely-watched-biotech-patent-case?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T14:55:26Z monthly 0.5 https://www.law360.com/appellate/articles/1491/teva-to-continue-selling-generic-vicoprofen-after-losing-vs-abbott-at-federal-circuit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T18:46:01Z monthly 0.5 https://www.law360.com/appellate/articles/1473/purdue-to-hold-off-on-oxycontin-generics-until-federal-circuit-ruling?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-10T22:49:04Z monthly 0.5 https://www.law360.com/appellate/articles/1475/canada-supreme-court-to-rule-in-monsanto-patent-case-on-friday?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T11:31:13Z monthly 0.5 https://www.law360.com/appellate/articles/1468/supreme-court-won-t-hear-copyright-case-over-l-a-riots-tape?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T01:14:03Z monthly 0.5 https://www.law360.com/appellate/articles/1429/arvinmeritor-wins-patent-interference-vs-eaton?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T18:50:11Z monthly 0.5 https://www.law360.com/appellate/articles/1436/federal-circuit-rules-for-elan-in-naproxen-patent-suit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T20:10:03Z monthly 0.5